{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:47:00Z","timestamp":1792482420185,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.modpat.2025.100915","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:15:20Z","timestamp":1760195720000},"page":"100915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Giant Cell-Rich Tumors of Bone and Soft Tissue"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6580-5137","authenticated-orcid":false,"given":"Robert M.","family":"van der Linde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.P.","family":"van IJzendoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"van de Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-0481","authenticated-orcid":false,"given":"Judith V.M.G.","family":"Bov\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2025.100915_bib1","series-title":"Practical Soft Tissue Pathology. A Diagnostic Approach","author":"Hornick","year":"2018"},{"key":"10.1016\/j.modpat.2025.100915_bib2","series-title":"Soft Tissue and Bone Tumours","year":"2020"},{"issue":"22","key":"10.1016\/j.modpat.2025.100915_bib3","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1158\/1078-0432.CCR-22-1898","article-title":"Interactions in CSF1-driven tenosynovial giant cell tumors","volume":"28","author":"van IJzendoorn","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(199602)166:2<311::AID-JCP9>3.0.CO;2-S","article-title":"Synthesis of membrane- and matrix-bound colony-stimulating factor-1 by cultured osteoblasts","volume":"166","author":"Felix","year":"1996","journal-title":"J Cell Physiol"},{"issue":"6656","key":"10.1016\/j.modpat.2025.100915_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI116179","article-title":"Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors","volume":"91","author":"Tanaka","year":"1993","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.modpat.2025.100915_bib7","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1210\/endo-127-5-2592","article-title":"Macrophage colony stimulating factor restores in vivo bone resorption in the op\/op osteopetrotic mouse","volume":"127","author":"Felix","year":"1990","journal-title":"Endocrinology"},{"issue":"6274","key":"10.1016\/j.modpat.2025.100915_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/345442a0","article-title":"The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene","volume":"345","author":"Yoshida","year":"1990","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.modpat.2025.100915_bib9","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","article-title":"Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL","volume":"95","author":"Yasuda","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"25","key":"10.1016\/j.modpat.2025.100915_bib10","doi-asserted-by":"crossref","first-page":"18245","DOI":"10.1074\/jbc.M610701200","article-title":"NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1","volume":"282","author":"Yamashita","year":"2007","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jbmr.5650010210","article-title":"Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures","volume":"1","author":"MacDonald","year":"1986","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.modpat.2025.100915_bib12","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/endo.139.3.5837","article-title":"Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro","volume":"139","author":"Yasuda","year":"1998","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib13","doi-asserted-by":"crossref","first-page":"5118","DOI":"10.4049\/jimmunol.157.11.5118","article-title":"Differential effects of macrophage- and granulocyte-macrophage colony-stimulating factors on cytokine gene expression during rat alveolar macrophage differentiation into multinucleated giant cells (MGC): role for IL-6 in type 2 MGC formation","volume":"157","author":"Lemaire","year":"1996","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib14","first-page":"BR420","article-title":"Interferon-\u03b3 impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes\/macrophages","volume":"10","author":"Reiss","year":"2004","journal-title":"Med Sci Monit"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1348-0421.2011.00380.x","article-title":"Tumor necrosis factor-\u03b1 can induce Langhans-type multinucleated giant cell formation derived from myeloid dendritic cells","volume":"55","author":"Yasui","year":"2011","journal-title":"Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/intimm\/dxr088","article-title":"The CD40\u2013CD40L axis and IFN-\u03b3 play critical roles in Langhans giant cell formation","volume":"24","author":"Sakai","year":"2012","journal-title":"Int Immunol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100915_bib17","first-page":"1487","article-title":"Interleukin-4 induces foreign body giant cells from human monocytes\/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells","volume":"147","author":"McNally","year":"1995","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100915_bib18","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.4049\/jimmunol.158.7.3385","article-title":"Interleukin-13 induces human monocyte\/macrophage fusion and macrophage mannose receptor expression","volume":"158","author":"DeFife","year":"1997","journal-title":"J Immunol"},{"issue":"5366","key":"10.1016\/j.modpat.2025.100915_bib19","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.280.5366.1036","article-title":"Landscaping the cancer terrain","volume":"280","author":"Kinzler","year":"1998","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.modpat.2025.100915_bib20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1073\/pnas.0507321103","article-title":"A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells","volume":"103","author":"West","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/BPET-F2PE-P2BD-J3P3","article-title":"RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone","volume":"117","author":"Roux","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100915_bib22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.modpat.2025.100915_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12253-016-0123-0","article-title":"Clinicopathological features of a series of 27 cases of post-denosumab treated giant cell tumors of bones: a single institutional experience at a Tertiary Cancer Referral Centre, India","volume":"23","author":"Rekhi","year":"2017","journal-title":"Pathol Oncol Res"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000001388","article-title":"Denosumab-treated giant cell tumors of bone: a clinicopathologic analysis of 35 cases from the French group of bone pathology","volume":"44","author":"Treffel","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100915_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/annonc\/mdn033","article-title":"Complete response to imatinib in relapsing pigmented villonodular synovitis\/tenosynovial giant cell tumor (PVNS\/TGCT)","volume":"19","author":"Blay","year":"2008","journal-title":"Ann Oncol"},{"issue":"10445","key":"10.1016\/j.modpat.2025.100915_bib27","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/S0140-6736(24)00885-7","article-title":"Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Gelderblom","year":"2024","journal-title":"Lancet"},{"issue":"10197","key":"10.1016\/j.modpat.2025.100915_bib29","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(19)30764-0","article-title":"Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial","volume":"394","author":"Tap","year":"2019","journal-title":"The Lancet"},{"issue":"15_suppl","key":"10.1016\/j.modpat.2025.100915_bib30","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.11078","article-title":"A phase I\/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS)","volume":"35","author":"Sankhala","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anndiagpath.2008.07.005","article-title":"Epidemiology of bone tumors in Mexico City: retrospective clinicopathologic study of 566 patients at a referral institution","volume":"13","author":"Baena-Ocampo L del","year":"2009","journal-title":"Ann Diagn Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100915_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00776-011-0033-7","article-title":"Giant cell tumour of bone: an analysis of 139 Indian patients","volume":"16","author":"Saikia","year":"2011","journal-title":"J Orthop Sci"},{"issue":"9","key":"10.1016\/j.modpat.2025.100915_bib33","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.5858\/arpa.2014-0432-OA","article-title":"Primary bone tumors: epidemiologic comparison of 9200 patients treated at Beijing Ji Shui Tan Hospital, Beijing, China, with 10 165 patients at Mayo Clinic, Rochester, Minnesota","volume":"139","author":"Niu","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"10.1016\/j.modpat.2025.100915_bib34","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/PAS.0000000000000715","article-title":"Histologic spectrum of giant cell tumor (GCT) of bone in patients 18 years of age and below: a study of 63 patients","volume":"40","author":"Al-Ibraheemi","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100915_bib35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/pin.13107","article-title":"Giant cell tumor of bone\u2014analysis of 213 cases involving extra-craniofacial bones","volume":"71","author":"Konishi","year":"2021","journal-title":"Pathol Int"},{"issue":"5","key":"10.1016\/j.modpat.2025.100915_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/17453674.2018.1490987","article-title":"Incidence and demographics of giant cell tumor of bone in The Netherlands: first nationwide Pathology Registry Study","volume":"89","author":"Verschoor","year":"2018","journal-title":"Acta Orthop"},{"key":"10.1016\/j.modpat.2025.100915_bib37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canep.2016.03.014","article-title":"Population-based study of giant cell tumor of bone in Sweden (1983\u20132011)","volume":"42","author":"Amelio","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100915_bib38","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1245\/s10434-009-0803-z","article-title":"Primary malignant giant-cell tumor of bone has high survival rate","volume":"17","author":"Domovitov","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.modpat.2025.100915_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3425221","article-title":"Malignant transformation of giant cell tumor of bone and the association with denosumab treatment: a radiology and pathology perspective","volume":"2022","author":"van Langevelde","year":"2022","journal-title":"Sarcoma"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/gcc.20656","article-title":"Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis","volume":"48","author":"Moskovszky","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.modpat.2025.100915_bib41","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.modpat.2025.100915_bib42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/PAS.0000000000000859","article-title":"H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone","volume":"41","author":"Amary","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100915_bib43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1309\/UC6KQHLD9LV2KENN","article-title":"Osteosarcoma: anatomic and histologic variants","volume":"125","author":"Klein","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100915_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100763","article-title":"Methylation analysis reveals epigenetic congruence between bone sarcomas with H3-3A mutations and malignant giant cell tumors of bone","volume":"38","author":"Saoud","year":"2025","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13887-y","article-title":"The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing","volume":"7","author":"Lim","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib46","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1038\/s41467-020-18955-y","article-title":"Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone","volume":"11","author":"Lutsik","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.modpat.2025.100915_bib47","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/s41418-022-01031-x","article-title":"Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone","volume":"29","author":"Cottone","year":"2022","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00361187","article-title":"Chondroblastoma: a clinical and radiological study of 104 cases","volume":"14","author":"Bloem","year":"1985","journal-title":"Skeletal Radiol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/1097-0142(197208)30:2<401::AID-CNCR2820300216>3.0.CO;2-B","article-title":"Benign chondroblastoma. A study of 125 cases","volume":"30","author":"Dahlin","year":"1972","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2025.100915_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100790","article-title":"Malignant chondroblastoma: an epigenetically distinct subtype of chondroblastoma with a predilection for the skeletally mature","volume":"38","author":"Fritchie","year":"2025","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib51","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41379-020-0604-2","article-title":"Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma","volume":"33","author":"Papke","year":"2020","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100915_bib52","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/his.14721","article-title":"Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant","volume":"81","author":"Gaeta","year":"2022","journal-title":"Histopathology"},{"issue":"6291","key":"10.1016\/j.modpat.2025.100915_bib53","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1126\/science.aae0065","article-title":"The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas","volume":"352","author":"Fang","year":"2016","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/mp.56.2.116","article-title":"Receptor activator of NF-\u03baB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment","volume":"56","author":"Huang","year":"2003","journal-title":"Mol Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100915_bib55","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/PAS.0000000000001568","article-title":"Chondroblastoma expresses RANKL by RNA in situ hybridization and may respond to denosumab therapy","volume":"44","author":"Suster","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib56","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib57","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/his.12945","article-title":"The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma","volume":"69","author":"Amary","year":"2016","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib58","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1002\/1097-0142(19880601)61:11<2291::AID-CNCR2820611125>3.0.CO;2-V","article-title":"Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology","volume":"61","author":"Martinez","year":"1988","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.modpat.2025.100915_bib59","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1002\/1097-0142(19920615)69:12<2921::AID-CNCR2820691210>3.0.CO;2-E","article-title":"Aneurysmal bone cyst. A clinicopathologic study of 238 cases","volume":"69","author":"Vergel De Dios","year":"1992","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1309\/AJCP33YDDJKFFTSV","article-title":"Differential diagnostic value of \u201cblue reticulated chondroid-like material\u201d in aneurysmal bone cysts: a classic histopathologic analysis of 215 cases","volume":"143","author":"Bahk","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib61","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1158\/0008-5472.CAN-03-2827","article-title":"USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst","volume":"64","author":"Oliveira","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.modpat.2025.100915_bib62","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)63432-3","article-title":"USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts","volume":"165","author":"Oliveira","year":"2004","journal-title":"Am J Pathol"},{"issue":"21","key":"10.1016\/j.modpat.2025.100915_bib63","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1038\/sj.onc.1208506","article-title":"Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes","volume":"24","author":"Oliveira","year":"2005","journal-title":"Oncogene"},{"issue":"47","key":"10.1016\/j.modpat.2025.100915_bib64","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.M110.175133","article-title":"TRE17\/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation","volume":"285","author":"Lau","year":"2010","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1016\/j.modpat.2025.100915_bib65","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1038\/onc.2010.116","article-title":"TRE17\/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-\u03baB","volume":"29","author":"Ye","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2013.03.005","article-title":"USP6-induced neoplasms: the biologic spectrum of aneurysmal bone cyst and nodular fasciitis","volume":"45","author":"Oliveira","year":"2014","journal-title":"Hum Pathol"},{"issue":"03","key":"10.1016\/j.modpat.2025.100915_bib67","first-page":"247","article-title":"Histopathogenesis of bone-and soft-tissue tumor spectrum with USP6 gene rearrangement: multiple partners involved in the tissue repair process","volume":"38","author":"Legrand","year":"2023","journal-title":"Histol Histopathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100915_bib68","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1066896920938878","article-title":"USP6-associated neoplasms: a rapidly expanding family of lesions","volume":"28","author":"Hiemcke-Jiwa","year":"2020","journal-title":"Int J Surg Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100915_bib69","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2106\/JBJS.20.00999","article-title":"The natural history of benign bone tumors of the extremities in asymptomatic children: a longitudinal radiographic study","volume":"103","author":"Collier","year":"2021","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib70","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12891-022-05330-9","article-title":"Non-ossifying fibromas and fibrous cortical defects around the knee - an epidemiologic survey in a Japanese pediatric population","volume":"23","author":"Emori","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.modpat.2025.100915_bib71","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4055\/cios.2014.6.3.305","article-title":"Incidental findings on knee radiographs in children and adolescents","volume":"6","author":"Seo","year":"2014","journal-title":"Clin Orthop Surg"},{"key":"10.1016\/j.modpat.2025.100915_bib72","first-page":"185","article-title":"The Appearance and Nature of cyst-like areas in the distal femoral metaphyses of children","volume":"46","author":"Sontag","year":"1941","journal-title":"Am J Roentgenol Radiat Ther"},{"issue":"4","key":"10.1016\/j.modpat.2025.100915_bib73","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00428-022-03341-4","article-title":"Oestrogen receptor expression distinguishes non-ossifying fibroma from other giant cell containing bone tumours","volume":"481","author":"Cleven","year":"2022","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib74","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/gim.2013.163","article-title":"Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder","volume":"16","author":"Stewart","year":"2014","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib75","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/path.5216","article-title":"Activating mutations in the MAP-kinase pathway define non-ossifying fibroma of bone","volume":"248","author":"Baumhoer","year":"2019","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib76","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/path.5259","article-title":"Non-ossifying fibroma: a RAS-MAPK driven benign bone neoplasm","volume":"248","author":"Bov\u00e9e","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.modpat.2025.100915_bib77","series-title":"Head and Neck Tumours","year":"2024"},{"issue":"8","key":"10.1016\/j.modpat.2025.100915_bib78","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/jop.12730","article-title":"Central giant cell lesion of the jaws: an updated analysis of 2270 cases reported in the literature","volume":"47","author":"Chrcanovic","year":"2018","journal-title":"J Oral Pathol Med"},{"issue":"9","key":"10.1016\/j.modpat.2025.100915_bib79","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hed.20069","article-title":"Incidence and disease-free survival after surgical therapy of central giant cell granulomas of the jaw in The Netherlands: 1990\u20131995","volume":"26","author":"de Lange","year":"2004","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.modpat.2025.100915_bib80","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3174\/ajnr.A7568","article-title":"Imaging features of craniofacial giant cell granulomas: a large retrospective analysis from a tertiary care center","volume":"43","author":"Chanda","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100915_bib81","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tripleo.2005.02.060","article-title":"Central giant cell granuloma of the jaws: a clinical, radiologic, and histopathologic study of 26 cases","volume":"101","author":"Kruse-L\u00f6sler","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"4","key":"10.1016\/j.modpat.2025.100915_bib82","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.oooo.2014.06.004","article-title":"Peripheral giant cell granulomas: a series of 279 cases","volume":"118","author":"Lester","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib83","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1067\/moe.2000.108438","article-title":"Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature","volume":"90","author":"von Wowern","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endodontology"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib84","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41467-018-06690-4","article-title":"TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw","volume":"9","author":"Gomes","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.modpat.2025.100915_bib85","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/jop.13048","article-title":"KRAS mutations in brown tumor of the jaws in hyperparathyroidism","volume":"49","author":"Guimar\u00e3es","year":"2020","journal-title":"J Oral Pathol Med"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib86","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/PAS.0000000000001257","article-title":"Giant cell lesions of the maxillofacial skeleton express RANKL by RNA in situ hybridization regardless of histologic pattern","volume":"43","author":"Stagner","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100915_bib87","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1600-0714.2010.00924.x","article-title":"Expression of receptor activator of NF-\u03baB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws","volume":"39","author":"Fanourakis","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.modpat.2025.100915_bib88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejca.2022.08.011","article-title":"RANKL inhibition for giant cell lesions of the jaw: a retrospective cohort analysis","volume":"175","author":"Schreuder","year":"2022","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib89","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/17453674.2017.1361126","article-title":"Higher incidence rates than previously known in tenosynovial giant cell tumors","volume":"88","author":"Mastboom","year":"2017","journal-title":"Acta Orthop"},{"issue":"4","key":"10.1016\/j.modpat.2025.100915_bib90","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/1097-0142(19860215)57:4<875::AID-CNCR2820570432>3.0.CO;2-Y","article-title":"Giant cell tumor of the tendon sheath (nodular tenosynovitis): a study of 207 cases to compare the large joint group with the common digit group","volume":"57","author":"Ushijima","year":"1986","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2025.100915_bib91","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.knee.2017.03.011","article-title":"Pigmented villonodular synovitis of the knee: a retrospective analysis of 214 cases at a UK tertiary referral centre","volume":"24","author":"Patel","year":"2017","journal-title":"The Knee"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib92","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1470-2045(19)30100-7","article-title":"Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study","volume":"20","author":"Mastboom","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib93","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41379-018-0129-0","article-title":"Malignant tenosynovial giant cell tumor: the true \u201csynovial sarcoma?\u201d A clinicopathologic, immunohistochemical, and molecular cytogenetic study of 10 cases, supporting origin from synoviocytes","volume":"32","author":"Al-Ibraheemi","year":"2019","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100915_bib94","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/jcp.54.5.404","article-title":"Giant cell tumour of tendon sheath (localised nodular tenosynovitis): clinicopathological features of 71 cases","volume":"54","author":"Monaghan","year":"2001","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100915_bib95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13000-022-01266-9","article-title":"Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue","volume":"17","author":"Sugita","year":"2022","journal-title":"Diagn Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100915_bib96","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/gcc.22807","article-title":"Detection of CSF1 rearrangements deleting the 3\u2032 UTR in tenosynovial giant cell tumors","volume":"59","author":"Ho","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"10.1016\/j.modpat.2025.100915_bib97","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/ijc.32421","article-title":"Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations","volume":"145","author":"Tsuda","year":"2019","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.modpat.2025.100915_bib98","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/s41379-020-0562-8","article-title":"Xanthogranulomatous epithelial tumor: report of 6 cases of a novel, potentially deceptive lesion with a predilection for young women","volume":"33","author":"Fritchie","year":"2020","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100915_bib99","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41379-021-00789-8","article-title":"Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors","volume":"34","author":"Agaimy","year":"2021","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib100","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41379-022-01115-6","article-title":"Xanthogranulomatous epithelial tumors and keratin-positive giant cell-rich soft tissue tumors: two aspects of a single entity with frequent HMGA2-NCOR2 fusions","volume":"35","author":"Dehner","year":"2022","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100915_bib101","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00428-024-03892-8","article-title":"Xanthogranulomatous epithelial tumors\/keratin-positive giant cell\u2013rich tumors involving the head and neck: report of seven cases and review of the literature","volume":"485","author":"Whaley","year":"2024","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib102","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00000478-199906000-00005","article-title":"Plexiform fibrohistiocytic tumor: clinicopathologic analysis of 22 cases","volume":"23","author":"Remstein","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100915_bib103","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200305000-00003","article-title":"Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations","volume":"27","author":"Dehner","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100915_bib104","doi-asserted-by":"crossref","DOI":"10.1002\/gcc.70010","article-title":"Novel HMGA2::COL14A1 fusion identified in xanthogranulomatous epithelial tumor\/keratin-positive giant cell tumor","volume":"63","author":"Dehner","year":"2024","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.modpat.2025.100915_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2023.11.006","article-title":"CSF1 expression in xanthogranulomatous epithelial tumor\/keratin-positive giant cell-rich tumor","volume":"143","author":"Dehner","year":"2024","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100915_bib106","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/annonc\/mdy129","article-title":"Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene","volume":"29","author":"Brahmi","year":"2018","journal-title":"Ann Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:50:10Z","timestamp":1781337010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225002133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0893395225002133"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100915","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Giant Cell-Rich Tumors of Bone and Soft Tissue","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"100915"}}